ras and myc analysis in primary and metastatic colorectal carcinomas: Specific ras mutations are associated with Dukes' D stage and mucinous histotype

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 293-300

  Albanese, Ida ^a   Rinaudo, Cira Daniela ^b   Alberti, Marcella ^a   Bazan, Viviana ^b   Russo, Antonio ^b   Migliavacca, Manuela ^b   Bazan, Pietro ^b   Dardanoni, Gabriella ^c   Tomasino, Rosa Maria ^b   La Farina, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Epidemiol Observ Ctr Sicilian R   (Italy)

Author keywords

c K ras 2; c myc; DNA ploidy; mucinous tumors; primary and metastatic colorectal carcinoma

Indexed keywords

RAS PROTEIN;

ADENOCARCINOMA; ARTICLE; COLORECTAL CARCINOMA; DNA SEQUENCE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MUTATION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR CELL;

EID: 12644251057     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
2. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989.
4. Scott N and Quirke P: Molecular biology of colorectal neoplasia. Gut 34: 289-292, 1993.
5. Ichii S, Takeda S, Horii A, Nakatsuru S, Miyoshi Y, Emi M, et al: Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 8: 2399-2405, 1993.
6. Laurent-Puig P, Olschwang S, Delattre O, Remvikos Y, Asselain B, Melot T, et al: Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102: 1136-1141, 1992.
7. Benhattar J, Losi L, Chaubert P, Givel J-C and Costa J: Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104: 1044-1048, 1993.
8. Finkelstein SD, Sayegh R, Christensen S and Swalsky PA: Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Cancer 71: 3827-3838, 1993.
9. Urosevic N, Krtolica K, Skaro-Milic A, Knezevic-Usaj S and Dujic A: Prevalence of G-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. Int J Cancer 54: 249-254, 1993.
10. Breivik J, Meling GI, Spurkland A, Rognum TO and Gaudernack G: K-ras mutation in colorectal cancer: relations to patient age, sex and tumor location. Br J Cancer 69: 367-371, 1994.
11. Phang T-W, Shi C-Y, Wee A, Ngoi S-S, Li B, Lee H-P and Ong C-N: K-ras mutation in colorectal carcinomas from Singapore. Int J Oncol 6: 191-195, 1995.
12. Kiaris H and Spandidos DA: Mutations of ras genes in human tumors (review). Int J Oncol 7: 413-421, 1995.
13. Heerdt BG, Molinas S, Deitch D and Augenlicht LH: Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene. Oncogene 6: 125-129, 1991.
14. Albanese I, Alberti M, Bazan V, Russo A, Baiamonte S, Migliavacca M, et al: Structural analysis of c-myc in human sporadic colorectal carcinoma. Anticancer Res 14: 1103-1106, 1994.
15. Dukes CE: The classification of cancer of rectum. J Pathol 35: 323-332, 1932.
16. Turnbull RB Jr, Kyle K, Watson FR and Spratt J: Cancer of the colon: the influence of no-touch isolation technique on survival rates. Ann Surg 166: 420-427, 1967.
17. Broders AC: The grading of carcinoma. Minn Med 8: 726-730, 1925.
18. Russo A, Bazan V, Plaja S, Leonardl P and Bazan P: Patterns of DNA-ploidy in operable colorectal carcinoma: a prospective study of 100 cases. J Surg Oncol 48: 4-10, 1991.
19. Tomasino RM, Daniele E, Bazan V, Morello V, Tralongo V, Nuara R, Nagar C, Salvato M, Ingria F, Restivo S, Dardanoni G, Vecchione A and Russo A: Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinico-pathological associations Cancer Res 55: 6103-6108, 1995.
20. La Farina M, Alberti M, Russo A, Bazan V, Grasso G, Romancino D, et al: Optimization of RNA and DNA purification procedures from human colorectal carcinomas. Anticancer Res 13: 1485-1490, 1993.
21. Marcu KB, Harris LJ, Stanton LW, Erikson J, Watt R and Croce CM: Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc Natl Acad Sci USA 80: 519-523, 1983.
22. Lawn RM, Efstratiadis A, O'Connell C and Maniatis T: The nucleotide sequence of the human β-globin gene. Cell 21: 647-651, 1980.
23. Yap EPH and McGee JO'D: Nonisotopic SSCP detection in PCR products by ethidium bromide staining. Trends Genet 8: 49, 1992.
24. Hongyo T, Buzard GS, Calvert RJ and Weghorst CM: 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res 21: 3637-3642, 1993.
25. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
26. Rogers BB, Alpert LC, Hine EAS and Buffone GJ: Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol 136: 541-548, 1990.
27. Koshiba M, Ogawa K, Hamazaki S, Sugiyama T, Ogawa O and Kitajima T: The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. Pathol Res Pract 189: 66-72, 1993.
28. Suchy B, Zietz C and Rabes HM: K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer 52: 30-33, 1992.
29. Losi L, Benhattar J and Costa J: Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 28A: 1115-1120, 1992.
30. Yamashita N, Minamoto T, Ochiai A, Onda M and Esumi H: Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 108: 434-440, 1995.
31. Kumar R, Sukumar S and Barbacid M: Activation of ras onco-genes preceding the onset of neoplasia. Science 248: 1101-1104, 1990.
32. Minamoto T, Yamashita N, Ochiai A, Mai M, Sugimura T, Ronai Z, et al: Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Cancer (Suppl) 75: 1520-1526, 1995.
33. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987.
34. Oudejans JJ, Slebos RJC, Zoetmulder FAN, Mooi WJ and Rodenhuis S: Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 49: 875-879, 1991.
35. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, et al: Prognostic value of p53 overexpression and c-K-ras gene mutations in colorectal cancer. Gastroenterology 104: 57-64, 1993.
36. Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ, et al: The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 59: 747-751, 1994.
37. Laurent-Puig P, Olschwang S, Delattre O, Validire P, Melot T, Mosseri V, Salmon RJ and Thomas G: Association of K-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int J Cancer 49: 220-223, 1991.
38. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, et al: Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 54: 33-35, 1994.
39. Moerkerk P, Arends JW, van Driel M, De Bruone A, De Goeij A and Ten Kate J: Type and number of K-ras point mutations relate to stage of human colorectal cancer. Cancer Res 54: 3376-3378, 1994.
40. Giaretti W, Pujic N, Rapallo A, Nigro S, Di Vinci A, Geido E, et at: K-ras 2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas. Gastroenterology 108: 1040-1047, 1995.
41. Burmer GC and Loeb LA: Mutations in the K-RAS-2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 86: 2403-2407, 1989.
42. Vassilev L and Johnson EM: An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. Mol Cell Biol 10: 4899-4904, 1990.
43. Bauer KD, Lincoln ST, Vera-Roman JM, Wallemark CB, Chmiel JS, Madurski ML, et al: Prognostic implications of proliferative activity and DNA aneuploidy in colonie adenocarcinomas. Lab Invest 57: 329-335, 1987.
44. Tachibana M, Deguchi N, Jitsukawa S, Baba S, Hata M and Tazaki H: Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer patients. J Urol 145: 963-967, 1991.